Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT02167451
Eligibility Criteria:
Inclusion Criteria:
* Ages 5 years and \</= 40 years
* All diagnoses
* Peripheral blood stem cells, marrow or cord blood
* All conditioning regimens
* Patient must be planned to receive a calcineurin inhibitor (cyclosporine or tacrolimus) together with steroid, methotrexate or mycophenolate mofetil as GVHD prophylaxis.
Exclusion Criteria:
* Documented anaphylaxis to Maraviroc
* Ex vivo T-cell (type of white blood cell) depleted grafts
* Abnormal Alanine Aminotransferase (ALT) (\>/=10X ULN) on day -3. (Assessed at study enrollment and confirmed again prior to the first dose of maraviroc.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
40 Years
Study:
NCT02167451
Study Brief:
Protocol Section:
NCT02167451